LBA16 Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP)
Saved in:
| Title: | LBA16 Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP) |
|---|---|
| Authors: | Mileshkin, L.1 (AUTHOR), Bochtler, T.2 (AUTHOR), Pauli, C.3 (AUTHOR), Durán-Pacheco, G.4 (AUTHOR), Arslan, C.5 (AUTHOR), Bigot, F.6 (AUTHOR), Chalabi, N.7 (AUTHOR), Cook, N.8 (AUTHOR), Italiano, A.9 (AUTHOR), Losa, F.10 (AUTHOR), Menezes, J.11 (AUTHOR), Michaud, C.7 (AUTHOR), Ozguroglu, M.12 (AUTHOR), Pazo Cid, R.A.13 (AUTHOR), Ross, J.S.14 (AUTHOR), Shiu, K-K.15 (AUTHOR), Stahl, M.16 (AUTHOR), Thomas, M.17 (AUTHOR), Moch, H.3 (AUTHOR), Krämer, A.18 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS1254-S1255. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
